Chaisson RE - Search Results

1

Health effects and exposure assessment of aerosolized pentamidine handlers.

McDiarmid MA, Fujikawa J, Schaefer J, Weinmann G, Chaisson RE, Hudson CA. McDiarmid MA, et al. Among authors: chaisson re. Chest. 1993 Aug;104(2):382-5. doi: 10.1378/chest.104.2.382. Chest. 1993. PMID: 8339622

2

Efficacy of engineering controls in reducing occupational exposure to aerosolized pentamidine.

McDiarmid MA, Schaefer J, Richard CL, Chaisson RE, Tepper BS. McDiarmid MA, et al. Among authors: chaisson re. Chest. 1992 Dec;102(6):1764-6. doi: 10.1378/chest.102.6.1764. Chest. 1992. PMID: 1446486

3

Human immunodeficiency virus-associated tuberculosis: update on prevention and treatment.

Dierberg KL, Chaisson RE. Dierberg KL, et al. Among authors: chaisson re. Clin Chest Med. 2013 Jun;34(2):217-28. doi: 10.1016/j.ccm.2013.02.003. Epub 2013 Apr 8. Clin Chest Med. 2013. PMID: 23702172 Free PMC article. Review.

4

Longitudinal assessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomes in an urban clinic.

Lucas GM, Gebo KA, Chaisson RE, Moore RD. Lucas GM, et al. Among authors: chaisson re. AIDS. 2002 Mar 29;16(5):767-74. doi: 10.1097/00002030-200203290-00012. AIDS. 2002. PMID: 11964533

5

Repeated administration of high-dose intermittent rifapentine reduces rifapentine and moxifloxacin plasma concentrations.

Dooley K, Flexner C, Hackman J, Peloquin CA, Nuermberger E, Chaisson RE, Dorman SE. Dooley K, et al. Among authors: chaisson re. Antimicrob Agents Chemother. 2008 Nov;52(11):4037-42. doi: 10.1128/AAC.00554-08. Epub 2008 Sep 2. Antimicrob Agents Chemother. 2008. PMID: 18765687 Free PMC article. Clinical Trial.

6

A Phase 2 Randomized Trial of a Rifapentine plus Moxifloxacin-Based Regimen for Treatment of Pulmonary Tuberculosis.

Conde MB, Mello FC, Duarte RS, Cavalcante SC, Rolla V, Dalcolmo M, Loredo C, Durovni B, Armstrong DT, Efron A, Barnes GL, Marzinke MA, Savic RM, Dooley KE, Cohn S, Moulton LH, Chaisson RE, Dorman SE. Conde MB, et al. Among authors: chaisson re. PLoS One. 2016 May 9;11(5):e0154778. doi: 10.1371/journal.pone.0154778. eCollection 2016. PLoS One. 2016. PMID: 27159505 Free PMC article. Clinical Trial.

7

Bactericidal activity of increasing daily and weekly doses of moxifloxacin in murine tuberculosis.

Yoshimatsu T, Nuermberger E, Tyagi S, Chaisson R, Bishai W, Grosset J. Yoshimatsu T, et al. Antimicrob Agents Chemother. 2002 Jun;46(6):1875-9. doi: 10.1128/AAC.46.6.1875-1879.2002. Antimicrob Agents Chemother. 2002. PMID: 12019103 Free PMC article.

8

Adherence to tuberculosis preventive therapy measured by urine metabolite testing among people with HIV.

Kendall EA, Durovni B, Martinson NA, Cavalacante S, Masonoke K, Saraceni V, Lebina L, Efron A, Cohn S, Chon S, Chaisson RE, Dowdy DW, Golub JE; THRio and TEKO teams. Kendall EA, et al. Among authors: chaisson re. AIDS. 2020 Jan 1;34(1):63-71. doi: 10.1097/QAD.0000000000002380. AIDS. 2020. PMID: 31567163 Free PMC article.

9

Mycobacterial infections and HIV.

Chaisson RE. Chaisson RE. Kekkaku. 1995 Apr;70(4):313-20. Kekkaku. 1995. PMID: 7760541 Review. No abstract available.

10

Tuberculosis drug resistance: a global threat.

Nachega JB, Chaisson RE. Nachega JB, et al. Among authors: chaisson re. Clin Infect Dis. 2003 Jan 15;36(Suppl 1):S24-30. doi: 10.1086/344657. Clin Infect Dis. 2003. PMID: 12516027

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

447 results

Search Page